GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cognetivity Neurosciences Ltd (XCNQ:CGN) » Definitions » Price-to-Free-Cash-Flow

Cognetivity Neurosciences (XCNQ:CGN) Price-to-Free-Cash-Flow : N/A (As of Jun. 12, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Cognetivity Neurosciences Price-to-Free-Cash-Flow?

As of today (2024-06-12), Cognetivity Neurosciences's share price is C$0.01. Cognetivity Neurosciences's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Oct. 2023 was C$-0.05. Hence, Cognetivity Neurosciences's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Cognetivity Neurosciences's Price-to-Free-Cash-Flow or its related term are showing as below:

XCNQ:CGN's Price-to-Free-Cash-Flow is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 16.58
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Cognetivity Neurosciences's Free Cash Flow per Share for the three months ended in Oct. 2023 was C$0.00. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was C$-0.05.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -14.20% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -9.50% per year.

During the past 7 years, Cognetivity Neurosciences's highest 3-Year average Free Cash Flow per Share Growth Rate was 19.70% per year. The lowest was -72.40% per year. And the median was -15.80% per year.


Cognetivity Neurosciences Price-to-Free-Cash-Flow Historical Data

The historical data trend for Cognetivity Neurosciences's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cognetivity Neurosciences Price-to-Free-Cash-Flow Chart

Cognetivity Neurosciences Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial - - - - -

Cognetivity Neurosciences Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Cognetivity Neurosciences's Price-to-Free-Cash-Flow

For the Health Information Services subindustry, Cognetivity Neurosciences's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cognetivity Neurosciences's Price-to-Free-Cash-Flow Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cognetivity Neurosciences's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Cognetivity Neurosciences's Price-to-Free-Cash-Flow falls into.



Cognetivity Neurosciences Price-to-Free-Cash-Flow Calculation

Cognetivity Neurosciences's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.01/-0.046
=N/A

Cognetivity Neurosciences's Share Price of today is C$0.01.
Cognetivity Neurosciences's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.05.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Cognetivity Neurosciences  (XCNQ:CGN) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Cognetivity Neurosciences Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Cognetivity Neurosciences's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Cognetivity Neurosciences (XCNQ:CGN) Business Description

Traded in Other Exchanges
Address
800 West Pender Street, Suite 1430, Vancouver, BC, CAN, V6C 2V6
Cognetivity Neurosciences Ltd is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical, commercial, and consumer environments for potentially allowing early diagnosis of dementia. The Company is considered operating in one segment for development of the ICA platform. Its geographical areas include Canada, United Kingdom and Dubai.
Executives
Ravinder Kang Director

Cognetivity Neurosciences (XCNQ:CGN) Headlines

No Headlines